Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a global public health threat. The efficacy of several repurposed drugs has been evaluated in clinical trials. Among these drugs, a second-generation antiandro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fei, Han, Ming, Dai, Pengfei, Xu, Wei, He, Juan, Tao, Xiaoting, Wu, Yang, Tong, Xinyuan, Xia, Xinyi, Guo, Wangxin, Zhou, Yunjiao, Li, Yunguang, Zhu, Yiqin, Zhang, Xiaoyu, Liu, Zhuang, Aji, Rebiguli, Cai, Xia, Li, Yutang, Qu, Di, Chen, Yu, Jiang, Shibo, Wang, Qiao, Ji, Hongbin, Xie, Youhua, Sun, Yihua, Lu, Lu, Gao, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870838/
https://www.ncbi.nlm.nih.gov/pubmed/33558541
http://dx.doi.org/10.1038/s41467-021-21171-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870838/
https://www.ncbi.nlm.nih.gov/pubmed/33558541
http://dx.doi.org/10.1038/s41467-021-21171-x

Ejemplares similares